Ningbo Menovo Pharm Co Ltd (603538) — Net Asset Quality Index
Ningbo Menovo Pharm Co Ltd (603538) has a Net Asset Quality Index of 63.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.73 Billion minus total liabilities of CN¥1.71 Billion yields net assets of CN¥3.03 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Ningbo Menovo Pharm Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Ningbo Menovo Pharm Co Ltd Net Asset Quality Index Over Time (2011–2025)
This chart shows how Ningbo Menovo Pharm Co Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the index stands at 63.9%, representing net assets of CN¥3.03 Billion against total assets of CN¥4.73 Billion CNY. For live market cap and overall valuation, see how much is Ningbo Menovo Pharm Co Ltd worth.
Annual Net Asset Quality Index for Ningbo Menovo Pharm Co Ltd (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Ningbo Menovo Pharm Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 603538 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 50.5% | CN¥2.45 Billion | CN¥4.85 Billion | CN¥2.40 Billion | ▲ +1.2 pp |
| 2024 | 49.3% | CN¥2.29 Billion | CN¥4.65 Billion | CN¥2.36 Billion | ▼ -0.1 pp |
| 2023 | 49.4% | CN¥2.19 Billion | CN¥4.42 Billion | CN¥2.24 Billion | ▲ +0.2 pp |
| 2022 | 49.2% | CN¥2.17 Billion | CN¥4.42 Billion | CN¥2.25 Billion | ▼ -0.3 pp |
| 2021 | 49.4% | CN¥1.98 Billion | CN¥4.00 Billion | CN¥2.02 Billion | ▼ -8.1 pp |
| 2020 | 57.5% | CN¥1.76 Billion | CN¥3.06 Billion | CN¥1.30 Billion | ▼ -2.5 pp |
| 2019 | 60.0% | CN¥1.57 Billion | CN¥2.61 Billion | CN¥1.05 Billion | ▲ +1.0 pp |
| 2018 | 59.0% | CN¥1.34 Billion | CN¥2.27 Billion | CN¥930.92 Million | ▼ -17.8 pp |
| 2017 | 76.8% | CN¥1.16 Billion | CN¥1.51 Billion | CN¥351.19 Million | ▲ +0.3 pp |
| 2016 | 76.5% | CN¥731.02 Million | CN¥955.29 Million | CN¥224.27 Million | ▼ -1.5 pp |
| 2015 | 78.0% | CN¥645.81 Million | CN¥827.64 Million | CN¥181.83 Million | ▲ +19.7 pp |
| 2014 | 58.4% | CN¥564.34 Million | CN¥966.89 Million | CN¥402.54 Million | ▲ +2.0 pp |
| 2013 | 56.4% | CN¥487.44 Million | CN¥864.69 Million | CN¥377.24 Million | ▲ +3.2 pp |
| 2012 | 53.2% | CN¥442.58 Million | CN¥831.58 Million | CN¥389.00 Million | ▼ -0.1 pp |
| 2011 | 53.3% | CN¥378.47 Million | CN¥709.97 Million | CN¥331.50 Million | — |